For Jennifer Rigby's latest contributions to The Japan Times, see below:
Spiez Laboratory was tasked last year by the WHO to be the first in a global network of high-security laboratories that will grow, store and share newly discovered microbes.
Making predictions are complex, scientists around the world said, but with cases doubling every two weeks, sustained transmission is likely to last several months and possibly longer.
The clinics on the front line of fighting the disease are financially stretched, leaving the U.S. and U.K. ill-equipped to tackle the first major global health test since the pandemic.
The world's inability to fund more Mosquirix shots dismays many in Africa. Children on the continent account for the vast majority of the roughly 600,000 global malaria deaths every year.
The proposal brought by the U.S. and others condemned Russia's actions but stopped short of immediately suspending its voting rights at the U.N. health agency.
The dominance of the relatively milder omicron variant and the availability of vaccines and treatments means governments should consider more strategic policies, some experts say.
Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.
Ukraine, a country of 44 million, has 2.3 million people with diabetes, 250,000 people living with HIV and around 160,000 cancer patients, according to the latest WHO estimates.
More than a third of women across all countries surveyed said that health workers had recommended a specific brand of formula to them.
